Eva Maria Trost-Gross

Title: Eva Maria Trost-Gross: Innovator in Bioconjugation Technology

Introduction

Eva Maria Trost-Gross is a notable inventor based in Wolfratshausen, Germany. She has made significant contributions to the field of bioconjugation technology, particularly through her innovative methods for producing polypeptide conjugates.

Latest Patents

One of her key patents is related to IGF-I poly (ethylene glycol) conjugates. This patent outlines a method for producing a polypeptide conjugated to poly (ethylene glycol). The process involves providing a nucleic acid encoding an expression construct, expressing this nucleic acid in a cell, and recovering the expression construct. Additionally, it includes the conjugation of a target peptide to poly (ethylene glycol) and the use of a specific trypsin mutant to produce the final polypeptide conjugate.

Career Highlights

Throughout her career, Eva has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop and refine her innovative techniques in bioconjugation.

Collaborations

Eva has collaborated with several professionals in her field, including Friederike Hesse and Eva Hoess. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Eva Maria Trost-Gross is a pioneering inventor whose work in bioconjugation technology has the potential to impact various applications in medicine and biotechnology. Her innovative methods and collaborations highlight her significant role in advancing this important field.